Literature DB >> 21575786

Blood pressure drugs have no mortality benefit in diabetic patients.

Eddie Vos, Colin P Rose, Pierre Biron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21575786      PMCID: PMC2782504          DOI: 10.1016/S0828-282X(09)70727-5

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  11 in total

1.  Blood-pressure reduction and cardiovascular risk in HOPE study.

Authors:  P Sleight; S Yusuf; J Pogue; R Tsuyuki; R Diaz; J Probstfield
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

2.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

3.  Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

Authors:  Robert W Schrier; Raymond O Estacio; Anne Esler; Philip Mehler
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

4.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

5.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

Authors:  Fiona Turnbull; Bruce Neal; Charles Algert; John Chalmers; Neil Chapman; Jeff Cutler; Mark Woodward; Stephen MacMahon
Journal:  Arch Intern Med       Date:  2005-06-27

9.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Authors:  R O Estacio; B W Jeffers; N Gifford; R W Schrier
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 10.  Hypertension in diabetes: a call to action.

Authors:  Norman R C Campbell; Lawrence A Leiter; Pierre Larochelle; Sheldon Tobe; Arun Chockalingam; Richard Ward; Dorothy Morris; Ross Tsuyuki
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.